Cordis Says Aneurysm Device Claims Invalid
Cordis Corp. on Friday struck back at infringement accusers Boston Scientific Corp. and Target Therapeutics Corp., saying that several claims in a patent disclosing a device for treating aneurysms should no...To view the full article, register now.
Already a subscriber? Click here to view full article